statistiche ricercatore

Continente	#
NA - Nord America	1.114
EU - Europa	441
AS - Asia	439
SA - Sud America	72
Continente sconosciuto - Info sul continente non disponibili	47
AF - Africa	32
OC - Oceania	1
Totale	2.146

Nazione	#
US - Stati Uniti d'America	1.082
IT - Italia	144
SG - Singapore	125
VN - Vietnam	84
RU - Federazione Russa	74
CN - Cina	72
HK - Hong Kong	68
BR - Brasile	52
DE - Germania	40
IE - Irlanda	33
SE - Svezia	30
FR - Francia	27
GB - Regno Unito	25
CI - Costa d'Avorio	22
BD - Bangladesh	20
UA - Ucraina	18
CA - Canada	17
IN - India	14
TR - Turchia	11
JP - Giappone	9
AR - Argentina	8
FI - Finlandia	8
BE - Belgio	7
ES - Italia	6
PL - Polonia	6
ID - Indonesia	5
MX - Messico	5
NL - Olanda	5
CR - Costa Rica	4
DK - Danimarca	4
EC - Ecuador	4
KR - Corea	4
ZA - Sudafrica	4
CO - Colombia	3
IQ - Iraq	3
PS - Palestinian Territory	3
AT - Austria	2
BA - Bosnia-Erzegovina	2
CL - Cile	2
CZ - Repubblica Ceca	2
GP - Guadalupe	2
HR - Croazia	2
IL - Israele	2
LT - Lituania	2
MY - Malesia	2
NP - Nepal	2
PK - Pakistan	2
PY - Paraguay	2
SA - Arabia Saudita	2
SV - El Salvador	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AU - Australia	1
BW - Botswana	1
CG - Congo	1
DZ - Algeria	1
ET - Etiopia	1
HN - Honduras	1
JO - Giordania	1
KE - Kenya	1
KH - Cambogia	1
KW - Kuwait	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MD - Moldavia	1
NI - Nicaragua	1
PE - Perù	1
PH - Filippine	1
PT - Portogallo	1
QA - Qatar	1
RS - Serbia	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TN - Tunisia	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.100

Nome	#
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study	215
Invasive Aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases	192
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study	189
Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards	181
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center	175
Candidemia in the elderly: What does it change?	163
Characterisation of candidemia in patients with recent surgery: A 7-year experience	160
Species distribution and antifungal susceptibilities of bloodstream Candida isolates: a nine-years single center survey	158
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience	149
Candidemia in Internal Medicine: Facing the New Challenge	146
Central venous catheter unrelated candidemia influences the outcome of infection in patients with solid tumors	127
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa	122
Ceftazidime–Avibactam in Critically Ill Patients: A Multicenter Observational Study	62
null	54
Severe acute Sars-Cov-2 infection and Long Covid: What Do We Know So Far? Epidemiology, Pathogenesis and new Challenges	53
Totale	2.146

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	78	0	0	0	0	0	3	9	1	12	10	16	27
2022/2023	270	18	26	14	14	18	69	3	18	52	1	26	11
2023/2024	149	21	3	12	15	20	40	2	21	2	3	1	9
2024/2025	326	42	16	14	10	10	25	29	19	43	46	35	37
2025/2026	932	84	47	58	77	94	46	183	77	83	74	67	42
2026/2027	198	35	31	21	86	25	0	0	0	0	0	0	0
Totale													2.146